FDA Approved: GOCOVRI — Supplemental Application (Adamas Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for GOCOVRI (amantadine) submitted by Adamas Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Levodopa-induced Dyskinesia
• Parkinson Disease

Drugs mentioned

• Gocovri (amantadine extended-release)

Snippet

SUPPL AP for GOCOVRI (AMANTADINE)